 | • レポートコード：GIR-107A14695 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、緑膿菌肺炎治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。緑膿菌肺炎治療薬の種類別市場規模（アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・緑膿菌肺炎治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aridis Pharmaceuticals LLC、Emergent BioSolutions Inc、MedImmune LLC、Polyphor Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アエルシン、EV-035、MEDI-3902、パノバクマブ、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・緑膿菌肺炎治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・緑膿菌肺炎治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・緑膿菌肺炎治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・緑膿菌肺炎治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・緑膿菌肺炎治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pseudomonas Aeruginosa Pneumonia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pseudomonas Aeruginosa Pneumonia Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Pseudomonas Aeruginosa Pneumonia Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pseudomonas Aeruginosa Pneumonia Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aerucin
EV-035
MEDI-3902
Panobacumab
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Pseudomonas Aeruginosa Pneumonia Drug market are listed below:
Aridis Pharmaceuticals LLC
Emergent BioSolutions Inc
MedImmune LLC
Polyphor Ltd
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pseudomonas Aeruginosa Pneumonia Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pseudomonas Aeruginosa Pneumonia Drug, with price, sales, revenue and global market share of Pseudomonas Aeruginosa Pneumonia Drug from 2019 to 2021.
Chapter 3, the Pseudomonas Aeruginosa Pneumonia Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pseudomonas Aeruginosa Pneumonia Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pseudomonas Aeruginosa Pneumonia Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pseudomonas Aeruginosa Pneumonia Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Pseudomonas Aeruginosa Pneumonia Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Aerucin
1.2.3 EV-035
1.2.4 MEDI-3902
1.2.5 Panobacumab
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size & Forecast
1.4.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Value (2016-2026))
1.4.2 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume (2016-2026)
1.4.3 Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Pseudomonas Aeruginosa Pneumonia Drug Production Capacity Analysis
1.5.1 Global Pseudomonas Aeruginosa Pneumonia Drug Total Production Capacity (2016-2026)
1.5.2 Global Pseudomonas Aeruginosa Pneumonia Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pseudomonas Aeruginosa Pneumonia Drug Market Drivers
1.6.2 Pseudomonas Aeruginosa Pneumonia Drug Market Restraints
1.6.3 Pseudomonas Aeruginosa Pneumonia Drug Trends Analysis
2 Manufacturers Profiles
2.1 Aridis Pharmaceuticals LLC
2.1.1 Aridis Pharmaceuticals LLC Details
2.1.2 Aridis Pharmaceuticals LLC Major Business
2.1.3 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Product and Services
2.1.4 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Emergent BioSolutions Inc
2.2.1 Emergent BioSolutions Inc Details
2.2.2 Emergent BioSolutions Inc Major Business
2.2.3 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Product and Services
2.2.4 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 MedImmune LLC
2.3.1 MedImmune LLC Details
2.3.2 MedImmune LLC Major Business
2.3.3 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Product and Services
2.3.4 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Polyphor Ltd
2.4.1 Polyphor Ltd Details
2.4.2 Polyphor Ltd Major Business
2.4.3 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Product and Services
2.4.4 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pseudomonas Aeruginosa Pneumonia Drug Sales by Manufacturer
3.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pseudomonas Aeruginosa Pneumonia Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Pseudomonas Aeruginosa Pneumonia Drug Manufacturer Market Share
3.4.2 Top 6 Pseudomonas Aeruginosa Pneumonia Drug Manufacturer Market Share
3.5 Global Pseudomonas Aeruginosa Pneumonia Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pseudomonas Aeruginosa Pneumonia Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size by Region
4.1.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region (2016-2026)
4.2 North America Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026)
4.3 Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026)
4.4 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026)
4.5 South America Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026)
4.6 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Type (2016-2026)
5.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type (2016-2026)
5.3 Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Application (2016-2026)
6.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Application (2016-2026)
6.3 Global Pseudomonas Aeruginosa Pneumonia Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2026)
7.2 North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2026)
7.3 North America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
7.3.1 North America Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2026)
8.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2026)
8.3 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
8.3.1 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size by Region
9.3.1 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2026)
10.2 South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2026)
10.3 South America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
10.3.1 South America Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
11.3.1 Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pseudomonas Aeruginosa Pneumonia Drug Typical Distributors
12.3 Pseudomonas Aeruginosa Pneumonia Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Aridis Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 4. Aridis Pharmaceuticals LLC Major Business
Table 5. Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Product and Services
Table 6. Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Emergent BioSolutions Inc Basic Information, Manufacturing Base and Competitors
Table 8. Emergent BioSolutions Inc Major Business
Table 9. Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Product and Services
Table 10. Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 12. MedImmune LLC Major Business
Table 13. MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Product and Services
Table 14. MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Polyphor Ltd Basic Information, Manufacturing Base and Competitors
Table 16. Polyphor Ltd Major Business
Table 17. Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Product and Services
Table 18. Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 20. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Pseudomonas Aeruginosa Pneumonia Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Pseudomonas Aeruginosa Pneumonia Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 23. Head Office and Pseudomonas Aeruginosa Pneumonia Drug Production Site of Key Manufacturer
Table 24. Pseudomonas Aeruginosa Pneumonia Drug New Entrant and Capacity Expansion Plans
Table 25. Pseudomonas Aeruginosa Pneumonia Drug Mergers & Acquisitions in the Past Five Years
Table 26. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 27. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2021-2026) & (K Pcs)
Table 28. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 31. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Pcs)
Table 32. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 35. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2021-2026) & (USD/Pcs)
Table 36. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 37. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Pcs)
Table 38. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 41. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Application (2021-2026) & (USD/Pcs)
Table 42. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 43. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Pcs)
Table 44. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 47. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Pcs)
Table 48. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 49. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Pcs)
Table 50. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 51. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Pcs)
Table 52. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 55. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Pcs)
Table 56. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 57. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Pcs)
Table 58. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 59. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2021-2026) & (K Pcs)
Table 60. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 63. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 65. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Pcs)
Table 66. South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 67. South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Pcs)
Table 68. South America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 71. South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Pcs)
Table 72. South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 73. South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 75. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Pcs)
Table 76. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 79. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 81. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Pcs)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Pseudomonas Aeruginosa Pneumonia Drug Typical Distributors
Table 85. Pseudomonas Aeruginosa Pneumonia Drug Typical Customers
List of Figures
Figure 1. Pseudomonas Aeruginosa Pneumonia Drug Picture
Figure 2. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type in 2020
Figure 3. Aerucin
Figure 4. EV-035
Figure 5. MEDI-3902
Figure 6. Panobacumab
Figure 7. Others
Figure 8. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application in 2020
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Pseudomonas Aeruginosa Pneumonia Drug Sales (2016-2026) & (K Pcs)
Figure 15. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Pseudomonas Aeruginosa Pneumonia Drug Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Pseudomonas Aeruginosa Pneumonia Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Pseudomonas Aeruginosa Pneumonia Drug Market Drivers
Figure 19. Pseudomonas Aeruginosa Pneumonia Drug Market Restraints
Figure 20. Pseudomonas Aeruginosa Pneumonia Drug Market Trends
Figure 21. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Pseudomonas Aeruginosa Pneumonia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Pseudomonas Aeruginosa Pneumonia Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Pseudomonas Aeruginosa Pneumonia Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の耐性緑膿菌感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Resistant Pseudomonas Aeruginosa Infections Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- 世界の肺炎治療薬市場 2021：企業別、地域別、種類・用途別 The Pneumonia Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界の甲状腺機能低下症治療薬市場 2021：企業別、地域別、種類・用途別 The Hypothyroidism Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の院内感染肺炎薬パイプライン分析市場予測（～2024年） Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being mu…
- 世界の薬物乱用検査サービス市場 2021：企業別、地域別、種類・用途別 The Drug of Abuse Testing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …